Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Fulcrum Therapeutics, Inc. (FULC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.6% stake in Fulcrum Therapeutics, Inc. |
| 08/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 13.4% stake in FULCRUM THERAPEUTICS, INC. |
| 06/22/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/10/2022 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.3% stake in Fulcrum Therapeutics, Inc. |
| 03/09/2022 |
SC 13G
| Cowen Financial Products LLC reports a 5.2% stake in Fulcrum Therapeutics Inc. |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/13/2020 |
SC 13G
| RTW INVESTMENTS, LP reports a 7.6% stake in Fulcrum Therapeutics, Inc. |
| 09/18/2020 |
SC 13G
| Point72 Asset Management, L.P. reports a 5% stake in Fulcrum Therapeutics, Inc. |
| 02/20/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/07/2020 |
SC 13G
| FMR LLC reports a 7.3% stake in FULCRUM THERAPEUTICS INC |
| 02/05/2020 |
SC 13G
| Third Rock Ventures III, L.P. reports a 25.5% stake in Fulcrum Therapeutics, Inc. |
| 02/05/2020 |
SC 13G
| Third Rock Ventures IV, L.P. reports a 10% stake in Fulcrum Therapeutics, Inc. |
| 07/29/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/26/2019 |
SC 13G
| Foresite Capital Fund IV, L.P. reports a 7.2% stake in Fulcrum Therapeutics, Inc. |
|
|